We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RKV market cap is 7.71M. The company's latest EPS is CAD -0.0373 and P/E is -5.36.
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -145k | -2.06M | -2.4M | -2.17M |
| Net Income | -191k | -5.52M | -2.79M | -2.61M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 813k | 8.66M | 6.12M | 5.15M |
| Total Liabilities | 42k | 114k | 107k | 1.49M |
| Total Equity | 771k | 8.54M | 6.01M | 3.66M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -69k | -2.31M | -1.92M | -1.86M |
| Investing | 6k | 800k | N/A | N/A |
| Financing | 397k | 4.32M | 2k | 1.4M |
| Market Cap | 7.71M |
| Price to Earnings Ratio | -5.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 32.26 |
| Price to Book Ratio | 3.83 |
| Dividend Yield | - |
| Shares Outstanding | 70.08M |
| Average Volume (1 week) | 33.6k |
| Average Volume (1 Month) | 36.22k |
| 52 Week Change | -21.43% |
| 52 Week High | 0.14 |
| 52 Week Low | 0.005 |
| Spread (Intraday) | 0.01 (4.55%) |
| Company Name | Rakovina Therapeutics Inc |
| Address |
720,999 west broadway vancouver, british columbia V5Z1K5 |
| Website | https://www.rakovinatherapeutics.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
